South Korean Diagnostics Leader Strengthens India’s MedTech Ecosystem Under ‘Make in India’
📍 Key Project Highlights
✅ Location: Reliance’s MET City, Jhajjar (Haryana) – A hub for 580+ global companies
✅ Facility Type: In-Vitro Diagnostics (IVD) manufacturing
✅ Strategic Alignment: Supports Make in India & Atmanirbhar Bharat in medtech
✅ Employment & Growth: Expected to boost local jobs & supply chains
✅ Global Footprint: 6th South Korean company at MET City
Why This Matters for India’s MedTech Sector
1. Advancing Self-Reliance in Diagnostics
- Reduces import dependence for critical IVD equipment & reagents
- Strengthens India’s position in the $50+ billion global IVD market
2. MET City’s Emergence as MedTech Hub
✔ Plug-n-Play infrastructure for MNCs
✔ 580+ companies from 10 countries (incl. 6 South Korean firms)
✔ Greenfield smart city with sustainability focus
3. Economic & Healthcare Impact
- Job creation in technical & manufacturing roles
- Boost to MSMEs in medical device supply chains
- Faster access to advanced diagnostics for Indian hospitals
Leadership Perspectives
Eui-Yul Choi, CEO & Chairman, Boditech Med:
“India is a strategic market and manufacturing base for global medtech. Our Jhajjar facility reflects our long-term commitment to serving Indian healthcare needs.”
SV Goyal, CEO, MET City:
“Boditech Med’s arrival cements MET City as a medtech hub. We welcome more global players to leverage our world-class infrastructure.”
Boditech Med’s Global Edge
🔬 Specialization: Rapid diagnostic tests, immunoassays, biochemistry analyzers
🌍 Presence: 100+ countries
🇮🇳 India Focus: Localized production for affordability & accessibility
MET City – India’s Industrial Beacon
🏭 Developed by: Reliance Industries (via Model Economic Township Ltd)
🌱 Sustainability: Solar power, water recycling, green spaces
🌐 Global Tenants: Diverse sectors from auto to medtech
What’s Next?
- Ramp-up of IVD production in 2025
- Potential R&D collaborations with Indian health institutes
- More South Korean investments expected at MET City
